VisionQuest Uses Artificial Intelligence to Screen 40,000 Patients for Diabetic Retinopathy
ALBUQUERQUE, New Mexico--(BUSINESS WIRE)-- #ai--VisionQuest Biomedical Inc. announces that the company has used the EyeStar artificial intelligence (AI) software to screen over 40,000 patients for diabetic retinopathy at the Clínicas del Azúcar. The EyeStar AI system screens patients for diabetic retinopathy and macular edema, conditions that lead to vision loss and blindness if left untreated. VisionQuest brought the EyeStar AI system to Clínicas del Azúcar in 2016, and since then the software has i